Publication | Open Access

Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma

First-line ProtocolsMedicinePathologyImmune Checkpoint InhibitorCancer TreatmentMetastatic Nasopharyngeal CarcinomaOncologyRadiation OncologyCisplatin-based Regimens